N-acetylcysteine and Contrast-Induced Nephrotoxicity
Author Information
Author(s): Gonzales Denise A, Norsworthy Kelly J, Kern Steven J, Banks Steve, Sieving Pamela C, Star Robert A, Natanson Charles, Danner Robert L
Primary Institution: National Institutes of Health
Hypothesis
Does N-acetylcysteine effectively prevent contrast-induced nephrotoxicity?
Conclusion
This meta-analysis does not support the efficacy of NAC to prevent contrast-induced nephrotoxicity.
Supporting Evidence
- Cluster 1 studies showed no benefit from NAC (RR = 0.87; p = 0.28).
- Cluster 2 studies indicated a large benefit from NAC treatment (RR = 0.15; p < 0.0001).
- Significant heterogeneity was detected among the trials (I2 = 37%; p = 0.04).
- Dialysis use across all studies did not suggest that NAC is beneficial (p = 0.42).
Takeaway
N-acetylcysteine (NAC) was tested to see if it helps prevent kidney problems from contrast dye, but it didn't work.
Methodology
The study included a meta-analysis of 22 randomized controlled trials with data extraction and clustering analysis.
Potential Biases
Publication bias was suggested by funnel plot asymmetry.
Limitations
The studies included showed significant heterogeneity and varied in quality.
Participant Demographics
The studies included a total of 2746 patients, with varying demographics across trials.
Statistical Information
P-Value
p = 0.04
Confidence Interval
95% CI 0.68–1.12
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website